LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 10

Search options

  1. Article ; Online: Unusually Divergent Ubiquitin Genes and Proteins in Plasmodium Species.

    Dalhuisen, Thomas / Plenderleith, Lindsey J / Ursani, Ismail / Philip, Nisha / Hahn, Beatrice H / Sharp, Paul M

    Genome biology and evolution

    2023  Volume 15, Issue 8

    Abstract: Ubiquitin is an extraordinarily highly conserved 76 amino acid protein encoded by three different types of gene, where the primary translation products are fusions either of ubiquitin with one of two ribosomal proteins (RPs) or of multiple ubiquitin ... ...

    Abstract Ubiquitin is an extraordinarily highly conserved 76 amino acid protein encoded by three different types of gene, where the primary translation products are fusions either of ubiquitin with one of two ribosomal proteins (RPs) or of multiple ubiquitin monomers from head to tail. Here, we investigate the evolution of ubiquitin genes in mammalian malaria parasites (Plasmodium species). The ubiquitin encoded by the RPS27a fusion gene is highly divergent, as previously found in a variety of protists. However, we also find that two other forms of divergent ubiquitin sequence, each previously thought to be extremely rare, have arisen recently during the divergence of Plasmodium subgenera. On two occasions, in two distinct lineages, the ubiquitin encoded by the RPL40 fusion gene has rapidly diverged. In addition, in one of these lineages, the polyubiquitin genes have undergone a single codon insertion, previously considered a unique feature of Rhizaria. There has been disagreement whether the multiple ubiquitin coding repeats within a genome exhibit concerted evolution or undergo a birth-and-death process; the Plasmodium ubiquitin genes show clear signs of concerted evolution, including the spread of this codon insertion to multiple repeats within the polyubiquitin gene.
    MeSH term(s) Animals ; Ubiquitin/genetics ; Polyubiquitin ; Ribosomal Proteins/genetics ; Magnoliopsida ; Plasmodium/genetics ; Mammals
    Chemical Substances Ubiquitin ; Polyubiquitin (120904-94-1) ; Ribosomal Proteins
    Language English
    Publishing date 2023-06-28
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 2495328-3
    ISSN 1759-6653 ; 1759-6653
    ISSN (online) 1759-6653
    ISSN 1759-6653
    DOI 10.1093/gbe/evad137
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: The prevalence of post COVID-19 condition (PCC) and a simple risk scoring tool for PCC screening on Bonaire, Caribbean Netherlands: a retrospective cohort study.

    Berry, Danytza / Dalhuisen, Thomas / Marchena, Giramin / Tiemessen, Ivo / Geubbels, Eveline / Jaspers, Loes

    medRxiv

    Abstract: Aim: To assess the prevalence of post COVID-19 condition (PCC) on Bonaire and develop a practical risk scoring tool for PCC screening, using easily obtainable characteristics. Methods: A retrospective cohort study of symptomatic SARS-CoV-2 cases were ... ...

    Abstract Aim: To assess the prevalence of post COVID-19 condition (PCC) on Bonaire and develop a practical risk scoring tool for PCC screening, using easily obtainable characteristics. Methods: A retrospective cohort study of symptomatic SARS-CoV-2 cases were randomly sampled from Bonaire their case-registry and telephone interviewed between 15-November-2021 and 4-December-2021. PCC patients had a PCR-positive SARS-CoV-2 test (1-March-2020 and 1-October-2021) and self-attributed at least one symptom lasting over four weeks to their infection. Multivariate logistic regression was used to derive a risk formula to develop a practical risk scoring tool. Results: Out of 414 cases, 160 (39%) were PCC patients. Fifty-three patients were unrecovered (median illness duration 250 days (IQR 34)). Of recovered patients, 35% experienced symptoms for at least 3 months after disease onset. PCC prevalence was highest among females (38%), 40-59 year-olds (40%), morbidly obese (31%) and hospitalized patients (80%). A PCC risk scoring tool using age, sex, presence of comorbidities, and acute phase hospitalization or GP visit had an area-under-the-curve (AUC) of 0.68 (95%CI 0.63-0.74). Adding smoking, alcohol use, BMI, education level, and number of acute phase symptoms increased the AUC to 0.79 (95%CI 0.74- 0.83). Subgroup analyses of non-hospitalized patients (n=362) resulted in similar AUCs. Conclusion: Thee estimated prevalence of PCC on Bonaire was 39%. Moreover, easily obtainable patient characteristics can be used to build a risk scoring tool for PCC with acceptable discriminatory power. After external validation, this tool could aid the development of healthcare interventions in low resource settings to identify patients at risk for PCC.
    Keywords covid19
    Language English
    Publishing date 2023-06-20
    Publisher Cold Spring Harbor Laboratory Press
    Document type Article ; Online
    DOI 10.1101/2023.06.20.23291646
    Database COVID19

    Kategorien

  3. Article ; Online: Discovery of lignin-transforming bacteria and enzymes in thermophilic environments using stable isotope probing.

    Levy-Booth, David J / Navas, Laura E / Fetherolf, Morgan M / Liu, Li-Yang / Dalhuisen, Thomas / Renneckar, Scott / Eltis, Lindsay D / Mohn, William W

    The ISME journal

    2022  Volume 16, Issue 8, Page(s) 1944–1956

    Abstract: Characterizing microorganisms and enzymes involved in lignin biodegradation in thermal ecosystems can identify thermostable biocatalysts. We integrated stable isotope probing (SIP), genome-resolved metagenomics, and enzyme characterization to investigate ...

    Abstract Characterizing microorganisms and enzymes involved in lignin biodegradation in thermal ecosystems can identify thermostable biocatalysts. We integrated stable isotope probing (SIP), genome-resolved metagenomics, and enzyme characterization to investigate the degradation of high-molecular weight,
    MeSH term(s) Bacteria/genetics ; Bacteria/metabolism ; Gammaproteobacteria/metabolism ; Isotopes/metabolism ; Lignin/metabolism ; Microbiota ; Tandem Mass Spectrometry
    Chemical Substances Isotopes ; Lignin (9005-53-2)
    Language English
    Publishing date 2022-05-02
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2406536-5
    ISSN 1751-7370 ; 1751-7362
    ISSN (online) 1751-7370
    ISSN 1751-7362
    DOI 10.1038/s41396-022-01241-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Plasma-based antigen persistence in the post-acute phase of COVID-19.

    Peluso, Michael J / Swank, Zoe N / Goldberg, Sarah A / Lu, Scott / Dalhuisen, Thomas / Borberg, Ella / Senussi, Yasmeen / Luna, Michael A / Chang Song, Celina / Clark, Alexus / Zamora, Andhy / Lew, Megan / Viswanathan, Badri / Huang, Beatrice / Anglin, Khamal / Hoh, Rebecca / Hsue, Priscila Y / Durstenfeld, Matthew S / Spinelli, Matthew A /
    Glidden, David V / Henrich, Timothy J / Kelly, J Daniel / Deeks, Steven G / Walt, David R / Martin, Jeffrey N

    The Lancet. Infectious diseases

    2024  

    Language English
    Publishing date 2024-04-08
    Publishing country United States
    Document type Letter
    ZDB-ID 2061641-7
    ISSN 1474-4457 ; 1473-3099
    ISSN (online) 1474-4457
    ISSN 1473-3099
    DOI 10.1016/S1473-3099(24)00211-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Mpox outbreak in the Netherlands, 2022: public health response, characteristics of the first 1,000 cases and protection of the first-generation smallpox vaccine.

    van Ewijk, Catharina E / Miura, Fuminari / van Rijckevorsel, Gini / de Vries, Henry Jc / Welkers, Matthijs Ra / van den Berg, Oda E / Friesema, Ingrid Hm / van den Berg, Patrick R / Dalhuisen, Thomas / Wallinga, Jacco / Brandwagt, Diederik / van Cleef, Brigitte Agl / Vennema, Harry / Voordouw, Bettie / Koopmans, Marion / van der Eijk, Annemiek A / Swaan, Corien M / Te Wierik, Margreet Jm / Leenstra, Tjalling /
    Op de Coul, Eline / Franz, Eelco

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

    2023  Volume 28, Issue 12

    Abstract: In early May 2022, a global outbreak of mpox started among persons without travel history to regions known to be enzootic for monkeypox virus (MPXV). On 8 August 2022, the Netherlands reported its 1,000th mpox case, representing a cumulative incidence of ...

    Abstract In early May 2022, a global outbreak of mpox started among persons without travel history to regions known to be enzootic for monkeypox virus (MPXV). On 8 August 2022, the Netherlands reported its 1,000th mpox case, representing a cumulative incidence of 55 per million population, one of the highest cumulative incidences worldwide. We describe characteristics of the first 1,000 mpox cases in the Netherlands, reported between 20 May and 8 August 2022, within the context of the public health response. These cases were predominantly men who have sex with men aged 31-45 years. The vast majority of infections were acquired through sexual contact with casual partners in private or recreational settings including LGBTQIA+ venues in the Netherlands. This indicates that, although some larger upsurges occurred from point-source and/or travel-related events, the outbreak was mainly characterised by sustained transmission within the Netherlands. In addition, we estimated the protective effect of first-generation smallpox vaccine against moderate/severe mpox and found a vaccine effectiveness of 58% (95% CI: 17-78%), suggesting moderate protection against moderate/severe mpox symptoms on top of any possible protection by this vaccine against MPXV infection and disease. Communication with and supporting the at-risk population in following mitigation measures remains essential.
    MeSH term(s) Male ; Humans ; Female ; Public Health ; Smallpox Vaccine ; Netherlands/epidemiology ; Homosexuality, Male ; Mpox (monkeypox)/diagnosis ; Mpox (monkeypox)/epidemiology ; Mpox (monkeypox)/prevention & control ; Travel ; Sexual and Gender Minorities ; Travel-Related Illness ; Disease Outbreaks/prevention & control ; Antigens, Viral ; Monkeypox virus
    Chemical Substances Smallpox Vaccine ; Antigens, Viral
    Language English
    Publishing date 2023-04-07
    Publishing country Sweden
    Document type Journal Article
    ZDB-ID 1338803-4
    ISSN 1560-7917 ; 1025-496X
    ISSN (online) 1560-7917
    ISSN 1025-496X
    DOI 10.2807/1560-7917.ES.2023.28.12.2200772
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Multimodal Molecular Imaging Reveals Tissue-Based T Cell Activation and Viral RNA Persistence for Up to 2 Years Following COVID-19.

    Peluso, Michael J / Ryder, Dylan / Flavell, Robert / Wang, Yingbing / Levi, Jelena / LaFranchi, Brian H / Deveau, Tyler-Marie / Buck, Amanda M / Munter, Sadie E / Asare, Kofi A / Aslam, Maya / Koch, Wally / Szabo, Gyula / Hoh, Rebecca / Deswal, Monika / Rodriguez, Antonio / Buitrago, Melissa / Tai, Viva / Shrestha, Uttam /
    Lu, Scott / Goldberg, Sarah A / Dalhuisen, Thomas / Durstenfeld, Matthew S / Hsue, Priscilla Y / Kelly, J Daniel / Kumar, Nitasha / Martin, Jeffrey N / Gambir, Aruna / Somsouk, Ma / Seo, Youngho / Deeks, Steven G / Laszik, Zoltan G / VanBrocklin, Henry F / Henrich, Timothy J

    medRxiv : the preprint server for health sciences

    2023  

    Abstract: The etiologic mechanisms of post-acute medical morbidities and unexplained symptoms (Long COVID) following SARS-CoV-2 infection are incompletely understood. There is growing evidence that viral persistence and immune dysregulation may play a major role. ... ...

    Abstract The etiologic mechanisms of post-acute medical morbidities and unexplained symptoms (Long COVID) following SARS-CoV-2 infection are incompletely understood. There is growing evidence that viral persistence and immune dysregulation may play a major role. We performed whole-body positron emission tomography (PET) imaging in a cohort of 24 participants at time points ranging from 27 to 910 days following acute SARS-CoV-2 infection using a novel radiopharmaceutical agent, [
    Language English
    Publishing date 2023-07-31
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2023.07.27.23293177
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Plasma-based antigen persistence in the post-acute phase of SARS-CoV-2 infection.

    Peluso, Michael J / Swank, Zoe N / Goldberg, Sarah A / Lu, Scott / Dalhuisen, Thomas / Borberg, Ella / Senussi, Yasmeen / Luna, Michael A / Song, Celina Chang / Clark, Alexus / Zamora, Andhy / Lew, Megan / Viswanathan, Badri / Huang, Beatrice / Anglin, Khamal / Hoh, Rebecca / Hsue, Priscila Y / Durstenfeld, Matthew S / Spinelli, Matthew A /
    Glidden, David V / Henrich, Timothy J / Daniel Kelly, J / Deeks, Steven G / Walt, David R / Martin, Jeffrey N

    medRxiv : the preprint server for health sciences

    2023  

    Abstract: Background: Persistent symptoms among some persons who develop COVID-19 has led to the hypothesis that SARS-CoV-2 may, in some form or location, persist for long periods following acute infection. Several studies have shown data in this regard but are ... ...

    Abstract Background: Persistent symptoms among some persons who develop COVID-19 has led to the hypothesis that SARS-CoV-2 may, in some form or location, persist for long periods following acute infection. Several studies have shown data in this regard but are limited by non-representative and small study populations, short duration since acute infection, and lack of a true-negative comparator group to assess assay specificity.
    Methods: We evaluated adults with RNA-confirmed COVID-19 at multiple time points following acute infection (pandemic-era participants) and adults with specimens collected prior to 2020 (pre-pandemic era). Using once-thawed plasma, we employed the Simoa
    Results: Compared to 250 pre-pandemic participants who had 2% assay positivity, detection of any SARS-CoV-2 antigen was significantly more frequent among 171 pandemic-era participants at three different time periods in the post-acute phase of infection. The absolute difference in SARS-CoV-2 plasma antigen prevalence was +11% (95% CI: +5.0% to +16%) at 3.0-6.0 months post-onset of COVID-19; +8.7% (95% CI: +3.1% to +14%) at 6.1 to 10.0 months; and +5.4% (95% CI: +0.42% to +10%) at 10.1-14.1 months. Hospitalization for acute COVID-19 and, among the non-hospitalized, worse self-reported health during acute COVID-19 were associated with greater post-acute phase antigen detection.
    Conclusions: Compared to uninfected persons, there is an excess prevalence of SARS-CoV-2 antigenemia in SARS-CoV-2-infected individuals up to 14 months after acute COVID-19. These findings motivate an urgent research agenda regarding the short-term and long-term clinical manifestations of this viral persistence.
    Language English
    Publishing date 2023-12-29
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2023.10.24.23297114
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Plasma-based antigen persistence in the post-acute phase of SARS-CoV-2 infection

    Peluso, Michael J. / Swank, Zoe N. / Goldberg, Sarah A. / Lu, Scott / Dalhuisen, Thomas / Borberg, Ella / Senussi, Yasmeen / Luna, Michael A. / Chang Song, Celina / Clark, Alexus / Zamora, Andhy / Lew, Megan / Viswanathan, Badri / Huang, Beatrice / Anglin, Khamal / Hoh, Rebecca / Hsue, Priscilla Y. / Durstenfeld, Matthew S. / Spinelli, Matthew A. /
    Glidden, David V. / Henrich, Timothy J. / Kelly, J. D. / Deeks, Steven G. / Walt, David R. / Martin, Jeffrey N.

    medRxiv

    Abstract: BACKGROUND: Although RNA viruses like SARS-CoV-2 are generally thought to be transient, the persistence of viral components beyond the acute phase can be driven by a variety of virologic and immunologic factors. Recent studies have suggested that SARS- ... ...

    Abstract BACKGROUND: Although RNA viruses like SARS-CoV-2 are generally thought to be transient, the persistence of viral components beyond the acute phase can be driven by a variety of virologic and immunologic factors. Recent studies have suggested that SARS-CoV-2 antigens may persist following COVID-19 but were limited by a lack of comparison to a large number of true negative control samples. METHODS: Using single molecule array (Simoa) assays for SARS-CoV-2 spike, S1, and nucleocapsid antigen in plasma from 171 pandemic-era individuals in the post-acute phase of SARS-CoV-2 infection and 250 pre-pandemic control samples, we compared prevalence of antigen detection. We used logistic regression models and prevalence ratios (PRs) to assess the relationship between demographic and disease factors and antigen persistence. RESULTS: Compared to the proportion of antigen positivity in the pre-pandemic controls (2%), detection of any SARS-CoV-2 antigen was more frequent across all post-acute COVID-19 time bins (3-6 months: 12.6%, p<0.001; 6-10 months, 10.7%, p=0.0002; 10-14 months, 7.5%, p=0.017). These differences were driven by spike protein for up to 14 months and nucleocapsid in the first 6 months after infection. The co-occurrence of multiple antigens at a single timepoint was uncommon. Hospitalization for acute COVID-19 (versus not hospitalized) and worse self-reported health during acute COVID-19 among those not hospitalized (versus more benign illness) were associated with higher prevalence of post-acute antigen detection (PR 1.86, p=0.03; PR 3.5, p=0.07, respectively) in the pandemic era. CONCLUSIONS: Our findings provide strong evidence that SARS-CoV-2 antigens can persist beyond the period of acute illness. The observation that more than 10% of plasma samples for over a year following initial SARS-CoV-2 infection contain detectable viral antigen, which are potentially immunogenic, has significant implications given the sheer number of people infected with SARS-CoV-2 to date. More work will be needed to determine whether these antigens have a causal role in post-acute sequelae of SARS-CoV-2 infection (PASC).
    Keywords covid19
    Language English
    Publishing date 2023-10-26
    Publisher Cold Spring Harbor Laboratory Press
    Document type Article ; Online
    DOI 10.1101/2023.10.24.23297114
    Database COVID19

    Kategorien

  9. Article ; Online: Multimodal Molecular Imaging Reveals Tissue-Based T Cell Activation and Viral RNA Persistence for Up to 2 Years Following COVID-19

    Peluso, Michael J. / Ryder, Dylan / Flavell, Robert / Wang, Yingbing / Levi, Jelena / LaFranchi, Brian H. / Deveau, Tyler-Marie / Buck, Amanda M. / Munter, Sadie E. / Asare, Kofi A. / Aslam, Maya / Koch, Wally / Szabo, Gyula / Hoh, Rebecca / Deswal, Monika / Rodriguez, Antonio / Buitrago, Melissa / Tai, Viva / Shrestha, Uttam /
    Lu, Scott / Goldberg, Sarah A. / Dalhuisen, Thomas / Durstenfeld, Matthew S. / Hsue, Priscilla Y. / Kelly, J. Daniel / Kumar, Nitasha / Martin, Jeffrey N. / Gambir, Aruna / Somsouk, Ma / Seo, Youngho / Deeks, Steven G. / Laszik, Zoltan G. / VanBrocklin, Henry F. / Henrich, Timothy J.

    medRxiv

    Abstract: The etiologic mechanisms of post-acute medical morbidities and unexplained symptoms (Long COVID) following SARS-CoV-2 infection are incompletely understood. There is growing evidence that viral persistence and immune dysregulation may play a major role. ... ...

    Abstract The etiologic mechanisms of post-acute medical morbidities and unexplained symptoms (Long COVID) following SARS-CoV-2 infection are incompletely understood. There is growing evidence that viral persistence and immune dysregulation may play a major role. We performed whole-body positron emission tomography (PET) imaging in a cohort of 24 participants at time points ranging from 27 to 910 days following acute SARS-CoV-2 infection using a novel radiopharmaceutical agent, [18F]F-AraG, a highly selective tracer that allows for anatomical quantitation of activated T lymphocytes. Tracer uptake in the post-acute COVID group, which included those with and without Long COVID symptoms, was significantly higher compared to pre-pandemic controls in many anatomical regions, including the brain stem, spinal cord, bone marrow, nasopharyngeal and hilar lymphoid tissue, cardiopulmonary tissues, and gut wall. Although T cell activation tended to be higher in participants imaged closer to the time of the acute illness, tracer uptake was increased in participants imaged up to 2.5 years following SARS-CoV-2 infection. We observed that T cell activation in spinal cord and gut wall was associated with the presence of Long COVID symptoms. In addition, tracer uptake in lung tissue was higher in those with persistent pulmonary symptoms. Notably, increased T cell activation in these tissues was also observed in many individuals without Long COVID. Given the high [18F]F-AraG uptake detected in the gut, we obtained colorectal tissue for in situ hybridization SARS-CoV-2 RNA and immunohistochemical studies in a subset of participants with Long COVID symptoms. We identified cellular SARS-CoV-2 RNA in rectosigmoid lamina propria tissue in all these participants, ranging from 158 to 676 days following initial COVID-19 illness, suggesting that tissue viral persistence could be associated with long-term immunological perturbations.
    Keywords covid19
    Language English
    Publishing date 2023-07-31
    Publisher Cold Spring Harbor Laboratory Press
    Document type Article ; Online
    DOI 10.1101/2023.07.27.23293177
    Database COVID19

    Kategorien

  10. Article ; Online: Multimodal Molecular Imaging Reveals Tissue-Based T Cell Activation and Viral RNA Persistence for Up to Two Years Following COVID-19

    Peluso, Michael J / Ryder, Dylan M / Flavell, Robert / Wang, Yingbing / Levi, Jelena / LaFranchi, Brian H / Deveau, Tyler-Marie M / Buck, Amanda M / Munter, Sadie E / Asare, Kofi A / Aslam, Maya / Koch, Walter / Szabo, Gyula / Hoh, Rebecca / Deswal, Monika / Rodriguez, Antonio / Buitrago, Melissa / Tai, Viva / Shrestha, Uttam /
    Lu, Scott / Goldberg, Sarah A / Dalhuisen, Thomas / Durstenfeld, Matthew S / Hsue, Priscilla Y / Kelly, J D / Kumar, Nitasha / Martin, Jeffrey N / Gambhir, Aruna / Somsouk, Ma / Seo, Youngho / Deeks, Steven G / Laszik, Zoltan G / VanBrocklin, Henry F / Henrich, Timothy J

    medRxiv

    Abstract: The etiologic mechanisms of post-acute medical morbidities and unexplained symptoms (Long COVID) following SARS-CoV-2 infection are incompletely understood. There is growing evidence that viral persistence and immune dysregulation may play a major role. ... ...

    Abstract The etiologic mechanisms of post-acute medical morbidities and unexplained symptoms (Long COVID) following SARS-CoV-2 infection are incompletely understood. There is growing evidence that viral persistence and immune dysregulation may play a major role. We performed whole-body positron emission tomography (PET) imaging in a cohort of 24 participants at time points ranging from 27 to 910 days following acute SARS-CoV-2 infection using a novel radiopharmaceutical agent, [18F]F-AraG, a highly selective tracer that allows for anatomical quantitation of activated T lymphocytes. Tracer uptake in the post-acute COVID group, which included those with and without Long COVID symptoms, was significantly higher compared to pre-pandemic controls in many anatomical regions, including the brain stem, spinal cord, bone marrow, nasopharyngeal and hilar lymphoid tissue, cardiopulmonary tissues, and gut wall. Although T cell activation tended to be higher in participants imaged closer to the time of the acute illness, tracer uptake was increased in participants imaged up to 2.5 years following SARS-CoV-2 infection. We observed that T cell activation in spinal cord and gut wall was associated with the presence of Long COVID symptoms. In addition, tracer uptake in lung tissue was higher in those with persistent pulmonary symptoms. Notably, increased T cell activation in these tissues was also observed in many individuals without Long COVID. Given the high [18F]F-AraG uptake detected in the gut, we obtained colorectal tissue for in situ hybridization SARS-CoV-2 RNA and immunohistochemical studies in a subset of participants with Long COVID symptoms. We identified cellular SARS-CoV-2 RNA in rectosigmoid lamina propria tissue in all these participants, ranging from 158 to 676 days following initial COVID-19 illness, suggesting that tissue viral persistence could be associated with long-term immunological perturbations.
    Keywords covid19
    Language English
    Publishing date 2023-07-31
    Publisher Cold Spring Harbor Laboratory Press
    Document type Article ; Online
    DOI 10.1101/2023.07.27.23293177
    Database COVID19

    Kategorien

To top